SAFETY OF THE ASSOCIATION OF RANOLAZINE AND IVABRADINE FOR ANTIANGINAL TREATMENT IN STABLE CORONARY ARTERY DISEASE

被引：0
|
作者：
Lupi, A. [1 ]
Schaffer, A. [2 ]
Mirabelli, F. [3 ]
Rognoni, A. [1 ]
Bongo, A. S. [1 ]
机构：
[1] AOU Maggiore della Carita, Cardiol Div 2, Novara, Italy
[2] Eastern Piedmont Univ, Cardiol Div 1, Vercelli, Italy
[3] ASL Biella, Outpatient Cardiol Serv, Biella, Italy
来源：
CARDIOLOGY | 2016年 / 134卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
097
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [21] Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials"
    Zhu, Houyong
    Xu, Xiaoqun
    Fang, Xiaojiang
    Zheng, Jianwu
    Zhao, Qian
    Chen, Tielong
    Huang, Jinyu
    CLINICAL THERAPEUTICS, 2020, 42 (02) : 376 - 377
  • [22] Ivabradine improves early diastolic coronary flow and flow reserve in patients with stable coronary artery disease
    Skalidis, E. I.
    Hamilos, M. I.
    Zacharis, E. A.
    Saloustros, H.
    Psathakis, M.
    Kochiadakis, G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2010, 31 : 787 - 787
  • [23] Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention
    Godino, Cosmo
    Colombo, Antonio
    Margonato, Alberto
    CLINICAL DRUG INVESTIGATION, 2017, 37 (02) : 105 - 120
  • [24] Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention
    Cosmo Godino
    Antonio Colombo
    Alberto Margonato
    Clinical Drug Investigation, 2017, 37 : 105 - 120
  • [25] Ivabradine and Carvedilol on Rest and Stress Coronary Diastolic Perfusion Time in Patients With Stable Coronary Artery Disease
    Tagliamonte, Ercole
    Rigo, Fausto
    Astarita, Costantino
    Astarita, Roberta
    Coppola, Antonino
    Tagliamonte, Maria Rosaria
    Capuano, Nicola
    CIRCULATION, 2016, 134
  • [26] Revascularization treatment of stable coronary artery disease
    Magro, Michael
    Garg, Scot
    Serruys, Patrick W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (02) : 195 - 212
  • [27] Antithrombotic Treatment of Stable Coronary Artery Disease
    Li, Yi-Heng
    Hsieh, I-Chang
    Ueng, Kwo-Chang
    Wang, Yu-Chen
    Cheng, Shu-Meng
    Wu, Cho-Kai
    Wu, Chiung-Jen
    Hsieh, Ming-Hsiung
    Jen, Hsu-Lung
    Chang, Chi-Jen
    Chen, Ying-Hwa
    ACTA CARDIOLOGICA SINICA, 2021, 37 (06) : 574 - 579
  • [28] Antiplatelet treatment in stable coronary artery disease
    Knight, CJ
    HEART, 2003, 89 (10) : 1273 - 1278
  • [29] Association of PCI with outcomes in stable coronary artery disease
    Price, J.
    Tao, M.
    Gupta, S.
    Gier, C.
    Pastena, P.
    Ibtida, I.
    Sharma, A.
    Mann, N.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Selective and Specific Inhibition of If with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure
    Prakash Deedwania
    Drugs, 2013, 73 : 1569 - 1586
12345